TY - JOUR
T1 - Expression and Function of β1 Integrins on Human Eosinophils
AU - Seminario, Maria Cristina
AU - Bochner, Bruce S.
PY - 1997
Y1 - 1997
N2 - Eosinophils preferentially accumulate at sites of chronic allergic diseases such as bronchial asthma. The mechanisms by which selective eosinophil migration occurs are not fully understood. However, interactions of cell-surface adhesion molecules on the eosinophil with molecular counterligands on endothelial and epithelial cells, and on extracellular matrix proteins, are likely to be critical during the recruitment process. One possible mechanism for selective eosinophil recruitment involves the α4β1 (VLA-4) integrin which is not expressed on neutrophils. Correlations have been found between infiltration of eosinophils and endothelial expression of VCAM-1, the ligand for VLA-4, in the lungs of asthmatic individuals as well as in late phase reactions in the lungs, nose and skin. Epithelial and endothelial cells respond to the Th2-type cytokines IL-4 and IL-13 with selective de novo expression of VCAM-1, consistent with the possible role of VCAM-1/VLA-4 interactions in eosinophil influx during allergic inflammation. Both β1 and β2 integrins on eosinophils exist in a state of partial activation. For example, eosinophils can be maximally activated for adhesion to VCAM-1 or fibronectin after exposure to β1 integrin-activating antibodies or divalent cations, conditions that do not necessarily affect the total cell surface expression of β1 integrins. In contrast, cytokines like IL-5 prevent β1 integrin activation while promoting β2 integrin function. Furthermore, ligation of integrins can regulate the effector functions of the cell. For example, eosinophil adhesion via β1 and/or β2 integrins has been shown to alter a variety of functional responses including degranulation and apoptosis. Thus, integrins appear to be important in mediating eosinophil migration and activation in allergic inflammation. Strategies that interfere with these processes may prove to be useful for treatment of allergic diseases.
AB - Eosinophils preferentially accumulate at sites of chronic allergic diseases such as bronchial asthma. The mechanisms by which selective eosinophil migration occurs are not fully understood. However, interactions of cell-surface adhesion molecules on the eosinophil with molecular counterligands on endothelial and epithelial cells, and on extracellular matrix proteins, are likely to be critical during the recruitment process. One possible mechanism for selective eosinophil recruitment involves the α4β1 (VLA-4) integrin which is not expressed on neutrophils. Correlations have been found between infiltration of eosinophils and endothelial expression of VCAM-1, the ligand for VLA-4, in the lungs of asthmatic individuals as well as in late phase reactions in the lungs, nose and skin. Epithelial and endothelial cells respond to the Th2-type cytokines IL-4 and IL-13 with selective de novo expression of VCAM-1, consistent with the possible role of VCAM-1/VLA-4 interactions in eosinophil influx during allergic inflammation. Both β1 and β2 integrins on eosinophils exist in a state of partial activation. For example, eosinophils can be maximally activated for adhesion to VCAM-1 or fibronectin after exposure to β1 integrin-activating antibodies or divalent cations, conditions that do not necessarily affect the total cell surface expression of β1 integrins. In contrast, cytokines like IL-5 prevent β1 integrin activation while promoting β2 integrin function. Furthermore, ligation of integrins can regulate the effector functions of the cell. For example, eosinophil adhesion via β1 and/or β2 integrins has been shown to alter a variety of functional responses including degranulation and apoptosis. Thus, integrins appear to be important in mediating eosinophil migration and activation in allergic inflammation. Strategies that interfere with these processes may prove to be useful for treatment of allergic diseases.
KW - Allergic diseases
KW - Eosinophil
KW - Interleukin
KW - β1 integrins
UR - http://www.scopus.com/inward/record.url?scp=0031311345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031311345&partnerID=8YFLogxK
U2 - 10.1590/S0074-02761997000800021
DO - 10.1590/S0074-02761997000800021
M3 - Article
C2 - 9698928
AN - SCOPUS:0031311345
SN - 0074-0276
VL - 92 SUPPL. 2
SP - 157
EP - 164
JO - Memorias do Instituto Oswaldo Cruz
JF - Memorias do Instituto Oswaldo Cruz
ER -